Cesar A. Briceno
Ophthalmology
3400 Civic Center Boulevard
West Pavilion, 3rd Floor
Philadelphia, PA 19104
West Pavilion, 3rd Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Variability Between Changes in Ocular Alignment and Gorman Diplopia Score After Teprotumumab in Thyroid Eye Disease.
Journal: Neuro-ophthalmology (Aeolus Press)
Published: September 04, 2026
Atypical orbital metastasis from invasive lobular breast carcinoma masquerading as a hordeolum.
Journal: BMJ case reports
Published: August 04, 2026
Development of a Core Outcome Domain Set for Facial Aging.
Journal: JAMA dermatology
Published: June 17, 2026
Efficacy and Safety of Satralizumab for Thyroid Eye Disease: Week 24 Results from the Phase 3 SatraGO-1 and SatraGO-2 Randomized Trials.
Journal: Ophthalmology
Published: April 29, 2026
The Minority Ophthalmology Mentoring Program: A Model for Increasing Diversity in Surgical Specialties.
Journal: Academic medicine : journal of the Association of American Medical Colleges
Published: April 27, 2026
GLP-1 Receptor Agonists and Risk of Skin Cancer in Adults With Type 2 Diabetes: A Target Trial Emulation.
Journal: Diabetes, obesity & metabolism
Published: April 22, 2026
Student-led efforts promoting inclusivity and belonging in US medical schools.
Journal: Nature medicine
Published: January 27, 2026
The role of monoclonal antibodies against IL-6 or IL-6R in the treatment of thyroid eye disease.
Journal: Reviews in endocrine & metabolic disorders
Published: October 29, 2025
Association Between Area Deprivation Index and Periocular Basal Cell Carcinoma Treated With Mohs Micrographic Surgery.
Journal: Ophthalmic plastic and reconstructive surgery
Published: September 23, 2025
Mohs-facilitated excision: A case series of a multidisciplinary approach to reduce local recurrence of advanced keratinocyte carcinomas.
Journal: Journal of the American Academy of Dermatology
Published: April 17, 2025
Observational Characterization of the Retreatment Course of Patients With Thyroid Eye Disease.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Published: January 09, 2025
Comparison of ophthalmic surgery rates in teprotumumab-treated vs. teprotumumab-untreated thyroid eye disease patients.
Journal: Arquivos brasileiros de oftalmologia
Published: October 23, 2024
Last Updated: 09/26/2026